LivaNova PLC (LIVN) CEO Damien McDonald on Q1 2022 Results - Earnings Call TranscriptSeeking Alpha • 05/08/22
LivaNova Initiates Targeted Commercial Launch of the Essenz Patient Monitor for Cardiopulmonary Bypass ProceduresBusiness Wire • 04/08/22
LivaNova Announces 250th Unipolar Depression Patient Implanted in RECOVER Clinical StudyBusiness Wire • 03/14/22
LivaNova Announces First Patient Implanted in OSPREY Clinical Study for Patients Coping with Obstructive Sleep ApneaBusiness Wire • 02/24/22
LivaNova PLC (LIVN) CEO Damien McDonald on Q4 2021 Results - Earnings Call TranscriptSeeking Alpha • 02/23/22
LivaNova to Present Scientific Data on VNS Therapy for Drug-Resistant Epilepsy at American Epilepsy Society 2021 Annual MeetingBusiness Wire • 12/02/21
LivaNova to Present Scientific Data on VNS Therapy for Difficult-to-Treat Depression at 4th International Brain Stimulation ConferenceBusiness Wire • 12/01/21
LivaNova to Present at the Piper Sandler 33rd Annual Virtual Healthcare ConferenceBusiness Wire • 11/23/21
LivaNova PLC (LIVN) CEO Damien McDonald on Q3 2021 Results - Earnings Call TranscriptSeeking Alpha • 11/06/21